Yellow Card Scheme
E55600
The Yellow Card Scheme is the United Kingdom’s national system for collecting and monitoring reports of suspected adverse reactions to medicines and medical devices to help ensure their safety.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Yellow Card Scheme canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T443402 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Yellow Card Scheme Context triple: [UK Medicines and Healthcare products Regulatory Agency, oversees, Yellow Card Scheme]
-
A.
Clipper card
The Clipper card is a reloadable contactless smart card used to pay fares across multiple public transit systems in the San Francisco Bay Area.
-
B.
ORCA card
The ORCA card is a reusable, contactless smart card used to pay fares across multiple public transit systems in the Puget Sound region of Washington State.
-
C.
Presto card
The Presto card is a reloadable smart card used for paying public transit fares across the Greater Toronto and Hamilton Area and other regions in Ontario, Canada.
-
D.
TAP card
The TAP card is a reusable contactless smart card used to pay fares across public transit systems in the Los Angeles County region.
-
E.
CharlieCard
The CharlieCard is a reusable contactless smart card used to pay fares on Boston's MBTA public transit system.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Yellow Card Scheme Target entity description: The Yellow Card Scheme is the United Kingdom’s national system for collecting and monitoring reports of suspected adverse reactions to medicines and medical devices to help ensure their safety.
-
A.
Clipper card
The Clipper card is a reloadable contactless smart card used to pay fares across multiple public transit systems in the San Francisco Bay Area.
-
B.
ORCA card
The ORCA card is a reusable, contactless smart card used to pay fares across multiple public transit systems in the Puget Sound region of Washington State.
-
C.
Presto card
The Presto card is a reloadable smart card used for paying public transit fares across the Greater Toronto and Hamilton Area and other regions in Ontario, Canada.
-
D.
TAP card
The TAP card is a reusable contactless smart card used to pay fares across public transit systems in the Los Angeles County region.
-
E.
CharlieCard
The CharlieCard is a reusable contactless smart card used to pay fares on Boston's MBTA public transit system.
- F. None of above. chosen
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
adverse event reporting system
ⓘ
pharmacovigilance system ⓘ |
| administeredBy |
UK Medicines and Healthcare products Regulatory Agency
ⓘ
surface form:
Medicines and Healthcare products Regulatory Agency
|
| appliesTo |
e‑cigarettes and refill containers
ⓘ
herbal remedies ⓘ medical devices ⓘ over‑the‑counter medicines ⓘ prescription medicines ⓘ vaccines ⓘ |
| associatedConcept | black triangle scheme ⓘ |
| collects |
reports of counterfeit or fake medicines
ⓘ
reports of defective medicines ⓘ reports of e‑cigarette side effects and safety concerns ⓘ reports of suspected adverse incidents involving medical devices ⓘ reports of suspected adverse reactions to biological medicines ⓘ reports of suspected adverse reactions to herbal medicines ⓘ reports of suspected adverse reactions to medicines ⓘ reports of suspected adverse reactions to vaccines ⓘ |
| country | United Kingdom ⓘ |
| dataUsedFor |
regulatory decisions on restrictions or withdrawal of products
ⓘ
signal detection of medicine safety issues ⓘ updating product information and warnings ⓘ |
| encouragesReportingOf |
adverse reactions in children
ⓘ
adverse reactions to black triangle medicines ⓘ new or unexpected adverse reactions ⓘ serious adverse reactions ⓘ |
| focusesOn | suspected adverse reactions rather than proven causality ⓘ |
| hasWebsite | https://yellowcard.mhra.gov.uk ⓘ |
| jurisdiction | United Kingdom ⓘ |
| language | English ⓘ |
| operatedBy |
UK Medicines and Healthcare products Regulatory Agency
ⓘ
surface form:
MHRA
UK Medicines and Healthcare products Regulatory Agency ⓘ
surface form:
Medicines and Healthcare products Regulatory Agency
|
| purpose |
collect reports of suspected adverse drug reactions
ⓘ
contribute to benefit–risk assessment of medicines ⓘ identify new or rare adverse reactions ⓘ monitor safety of medical devices ⓘ monitor safety of medicines ⓘ support regulatory action on medicine safety ⓘ |
| relatedTo | pharmacovigilance in the United Kingdom ⓘ |
| reportingMethod |
mobile application
ⓘ
online form ⓘ paper form ⓘ |
| reportsCanBeSubmittedBy |
carers
ⓘ
dentists ⓘ doctors ⓘ healthcare professionals ⓘ nurses ⓘ patients ⓘ pharmacists ⓘ |
| supportedBy |
UK Medicines and Healthcare products Regulatory Agency
ⓘ
surface form:
Commission on Human Medicines
|
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Yellow Card Scheme Description of subject: The Yellow Card Scheme is the United Kingdom’s national system for collecting and monitoring reports of suspected adverse reactions to medicines and medical devices to help ensure their safety.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.